Midline Gliomas: A Retrospective Study from a Cancer Center in the Middle East.

Al Sharie, Sarah; Abu Laban, Dima; Nazzal, Jamil; Iqneibi, Shahad; Ghnaimat, Sura; Al-Ani, Abdallah; Al-Hussaini, Maysa

Al Sharie, Sarah; Abu Laban, Dima; Nazzal, Jamil; Iqneibi, Shahad; Ghnaimat, Sura; Al-Ani, Abdallah; Al-Hussaini, Maysa.

Afiliação

Al Sharie S; Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan.
Abu Laban D; Department of Radiology, King Hussein Cancer Center, Amman 11941, Jordan.
Nazzal J; Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan.
Iqneibi S; Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan.
Ghnaimat S; Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan.
Al-Ani A; Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan.
Al-Hussaini M; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman 11941, Jordan.

Cancers (Basel) ; 15(18)2023 Sep 13.

Article em En | MEDLINE | ID: mdl-37760513

Palavras-chave

H3 K27M mutation; H3 K27me3 alteration; brainstem; circumscribed glioma; corpus callosum; diffuse midline glioma (DMG); spinal cord; thalamus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Jordânia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google